Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
Zurich (ots/PRNewswire) - Neurimmune, a global leader in the discovery and development of human-derived monoclonal antibodies, today announced that it has entered into a collaboration with Ono Pharmaceutical Co., Ltd. focused on the development of human antibodies against a novel therapeutic target for neurodegenerative diseases. Under the terms of the collaboration ...
plus